Elevate your hospital’s cell collections with personalized support from a partner with global expertise.
In an era when healthcare resources seem permanently strained, your hospital staff are likely challenged to both provide a comfortable patient experience and ensure the highest-quality cell collections, all amid increasing demand for patient therapies and ongoing research. Our cell collection services leverage data and insights we’ve assembled from global use of our apheresis systems to map a game-changing path forward for your cell collections team.
Through optimized apheresis procedures, our collaborative solutions balance your patients’ unique needs and goals with biotech and life science organizations’ stringent requirements for quality and volume of starting materials. The results? Opportunities for a better patient experience and better therapy outcomes.
Webinar
Timing cell collections can be a challenge for patients in fragile health. A panel of physician and industry experts from Dendreon, BioInsights Publishing, Crispr Therapeutics, Georgia Institute of Technology, and Emory University recently gathered to discuss these challenges in a question-and-answer session. Hear from them how standard training, requirement quality, and assessing a patient's precount can improve the bottlenecks in your process. Implementing Veda Insights services, we analyze your institutional data to pinpoint the ideal target cell yield for patients. This can help your teams as they work to optimize timing, reduce patient risk, and enhance high-quality blood cell collection.
View their expert insights on demand.
Healthcare workers at University Clinic Saint-Luc in Brussels, Belgium, like countless other large health institutions, needed to reduce errors and minimize workflow stress. Head of Hematology Catherine Lambert, MD, in a conversation with our Global Data Services Manager, Sara Lewandowski, shares her team’s successes with data analytics that bridged the gap in their cell collection procedures and improved system and staff workload.
Take a deep dive into the conversation.
Presentation
Each patient’s needs are unique. That’s why we’re committed to helping standardize hospital cell collection with clear and simple procedural guidance. With the right data and knowledge, you can reduce the frequency of device alarms to collect the ideal volume of blood for each patient’s needs. Our Spectra Optia® Prediction Algorithm is a valuable analytic that sets cell collection targets against benchmarks based on an individual patient’s precount — and helps establish a balanced plan for your future apheresis collections.
Hear how data solutions can equip you for success.
Case Study
Collecting peripheral stem cells by apheresis is significantly more challenging for certain patients, including those with sickle cell disease, as it requires many days and cell collection cycles to achieve the target yield needed for therapies. Working with Boston Children’s Hospital and Harvard Medical School through a National Institutes of Health-funded grant, our Spectra Optia system experts showed operators how to interpret valuable data for these patient groups — including collecting cells from a deeper layer within the buffy coat and carefully managing inlet pump flow rates to minimize access pressure alarms and delays.
Learn how data analytics can help.
All products and solutions may not be available in all regions. Contact your Terumo Blood and Cell Technologies representative.